| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (300 MG) | 00438014 | Marketed | Baxter Corporation | Jan 2013 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP (900 MG) | 00786292 | Marketed | Baxter Corporation | Jan 2013 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP (900 MG) | 00786209 | Marketed | Baxter Corporation | Jan 2013 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (450 MG) | 00437999 | Marketed | Baxter Corporation | Jan 2013 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP (900 MG) | 00786217 | Marketed | Baxter Corporation | Jan 2013 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (300 MG) | 00438022 | Marketed | Baxter Corporation | Jan 2013 |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (450 MG) | 00438006 | Marketed | Baxter Corporation | Jan 2013 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP (200 MG) | 01931598 | Marketed | B. Braun Medical AG | Oct 1998 |
| 0.45% SODIUM CHLORIDE INJECTION USP (4.5 MG) | 01927949 | Marketed | B. Braun Medical AG | Apr 1998 |
| 0.9% SODIUM CHLORIDE INJECTION (900 MG) | 02395150 | Marketed | Fresenius Kabi Canada Ltd | Feb 2023 |
| 0.9% SODIUM CHLORIDE INJECTION USP (0.9 %) | 01924303 | Marketed | B. Braun Medical AG | Apr 1998 |
| 0.9% SODIUM CHLORIDE INJECTION USP (9 MG) | 02150204 | Marketed | Omega Laboratories Limited | Jul 2020 |
| 0.9% SODIUM CHLORIDE INJECTION USP (9 MG) | 02304341 | Marketed | Hikma Canada Limited | May 2024 |
| 0.9% SODIUM CHLORIDE INJECTION, USP (900 MG) | 00060208 | Marketed | Baxter Corporation | Feb 2019 |
| 0.9% SODIUM CHLORIDE IRRIGATION, USP (900 MG) | 00786160 | Marketed | Baxter Corporation | Jan 2021 |
| 12% SODIUM CHLORDIE PROCESSING SOLUTION (12 G) | 00783625 | Marketed | Baxter Corporation | Dec 1991 |
| 20% SODIUM CHLORIDE INJECTION, BP (20 %) | 02514184 | Marketed | Baxter Corporation | Jul 2022 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (450 MG) | 01927531 | Marketed | B. Braun Medical AG | May 1998 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP (9 MG) | 01924435 | Marketed | B. Braun Medical AG | May 1998 |
| 5% SODIUM CHLORIDE INJECTION USP (5 G) | 01928007 | Marketed | B. Braun Medical AG | Apr 1998 |
| ACID CONCENTRATE 2156 (268 G) | 02239491 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE 2182 (262.98 G) | 02210835 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE A1221 (263 G) | 02254344 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1222 (263 G) | 02254336 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1223 (263 G) | 02254328 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1224 (263 G) | 02254301 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1225 (263.0 G) | 02254298 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1226 (263 G) | 02254255 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1227 (263.0 G) | 02254247 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1228 (263 G) | 02533774 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1230 (275 G) | 02254085 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1231 (275 G) | 02533855 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1241 (268 G) | 02533782 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1242 (268 G) | 02533847 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1243 (268 G) | 02533758 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1245 (268 G) | 02533812 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1246 (268 G) | 02533820 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1252 (275 G) | 02533839 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1255 (275 G) | 02533766 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1261 (263 G) | 02262479 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1262 (263 G) | 02262487 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1263 (263 G) | 02533871 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1265 (263 G) | 02533863 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1266 (263 G) | 02262525 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1267 (263 G) | 02533898 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1270 (263 G) | 02272512 | Marketed | Chief Medical Supplies Ltd | Jan 2026 |
| ACID CONCENTRATE A1275 (263 G) | 02272563 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1277 (263 G) | 02272598 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1279 (263 G) | 02272628 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1294 (263 G) | 02268728 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1296 (263 G) | 02435918 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1297 (263 G) | 02435969 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1298 (263 G) | 02435950 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE D12201 (263 G) | 00860565 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12207 (263 G) | 00890197 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12236 (263 G) | 02217244 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12248 (263 G) | 02158329 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12262 (263 G) | 02158221 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12264 (263 G) | 02158159 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12272 (263 G) | 02178125 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12275 (263 G) | 02218879 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12286 (263 G) | 02217252 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12290 (263 G) | 02217643 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12291 (263 G) | 02217279 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12293 (263 G) | 02217554 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12294 (263 G) | 02217619 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12299 (263 G) | 02217260 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12300 (263 G) | 02217597 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12302 (263 G) | 02217635 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12305 (263 G) | 02217600 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12316 (263 G) | 02178168 | Marketed | Vantive Ulc | May 2024 |
| ADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM) (8.77 G) | 02444097 | Marketed | Maco Pharma | Aug 2016 |
| AMO ENDOSOL SOLUTION (0.64 %) | 02007967 | Marketed | Amo Canada Company | Apr 2003 |
| AVL ELECTROLYTE CONCENTRATE (5.9 G) | 02384655 | Marketed | Alberta Veterinary Laboratories Ltd | Mar 2014 |
| AVL ELECTROLYTE POWDER (3.507 G) | 02384248 | Marketed | Alberta Veterinary Laboratories Ltd | Nov 2024 |
| AVL ELECTROLYTE POWDER HE (3.507 G) | 02408309 | Marketed | Alberta Veterinary Laboratories Ltd | May 2024 |
| BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP (9 MG) | 00037818 | Marketed | Pfizer Canada Ulc | Aug 2017 |
| BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM (5.64 G) | 02261057 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM (5.64 G) | 02261073 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM (5.64 G) | 02261065 | Marketed | Fresenius Medical Care Canada Inc | May 2021 |
| BI-PEGLYTE (1.46 G) | 02326302 | Marketed | Pendopharm Division Of Pharmascience Inc | Jun 2010 |
| BICART SELECT COMBI-PAK (1200 G) | 02425246 | Marketed | Vantive Ulc | May 2024 |
| BSS PLUS (0.714 %) | 00568082 | Marketed | Alcon Canada Inc. | Dec 1982 |
| BSS STERILE IRRIGATING SOLUTION (0.64 %) | 00512990 | Marketed | Alcon Canada Inc. | Nov 2008 |
| CALF-LYTE II (3.507 G) | 02242113 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-LYTE II HE (3.507 G) | 02242114 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-QUENCH HE (3.507 G) | 02495775 | Marketed | Dominion Veterinary Laboratories Ltd. | Oct 2025 |
| CLINIMIX E (58.5 MG) | 02014076 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (58.5 MG) | 02013967 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (58.5 MG) | 02142384 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (205 MG) | 02498413 | Marketed | Baxter Corporation | Oct 2021 |
| CLINIMIX E (205 MG) | 02498421 | Marketed | Baxter Corporation | Dec 2020 |
| COLYTE (20.87 MG) | 00677442 | Marketed | Pendopharm Division Of Pharmascience Inc | Apr 2013 |
| DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION (900 MG) | 00783641 | Marketed | Baxter Corporation | Dec 1991 |
| DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ (900 MG) | 00060755 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ (300 MG) | 00060712 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ (200 MG) | 00060704 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ (450 MG) | 00060739 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ (900 MG) | 00060747 | Marketed | Baxter Corporation | Dec 1990 |
| DIANEAL PD101 CAPD SOLUTION WITH 0.5% DEXTROSE (567 MG) | 00799793 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 1.5% DEXTROSE (567 MG) | 00799815 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 2.5% DEXTROSE (567 MG) | 00799823 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 4.25% DEXTROSE (567 MG) | 00799807 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM (538 MG) | 00865095 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM (538 MG) | 00865109 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM (538 MG) | 00865117 | Marketed | Vantive Ulc | Apr 2024 |
| ELECTROVITE (.66 MG) | 00580007 | Marketed | Dominion Veterinary Laboratories Ltd. | Dec 1983 |
| EXTRANEAL (5.35 G) | 02240806 | Marketed | Vantive Ulc | Apr 2024 |
| GERME ZONE (908 G) | 00097403 | Marketed | Dominion Veterinary Laboratories Ltd. | Dec 1951 |
| GLYCERINATED PHENOL SALINE (0.9 %) | 00298417 | Marketed | Alk-Abello Inc | Jan 2005 |
| HEMOSATE ULTRA HS1125 (263 G) | 02413892 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2125 (263 G) | 02413906 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS3125 (263 G) | 02413914 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS4125 (263 G) | 02413922 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEPARIN SOD AND 0.9% SOD CHLORIDE INJ (9 MG) | 00828750 | Marketed | Baxter Corporation | Dec 1990 |
| HYPERSALINE 7.2% (7.2 G) | 02427672 | Marketed | Dmvet Inc | Oct 2014 |
| ISOLYTE S (MULTI-ELECTROLYTE INJECTION) (530 MG) | 01931628 | Marketed | B. Braun Medical AG | Jun 1998 |
| ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION) (530 MG) | 01931679 | Marketed | B. Braun Medical AG | Jun 1998 |
| JAMPLYTE (5.84 G) | 02378329 | Marketed | JAMP Pharma Corporation | Jun 2025 |
| JAMPLYTE + BISACODYL (1.46 G) | 02552612 | Marketed | JAMP Pharma Corporation | Aug 2025 |
| LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP (600 MG) | 00061131 | Marketed | Baxter Corporation | Dec 1973 |
| LACTATED RINGER'S INJ (600 MG) | 00881600 | Marketed | Baxter Corporation | Dec 1991 |
| LACTATED RINGER'S INJECTION (6 MG) | 00039470 | Marketed | Icu Medical Canada Inc | Dec 2019 |
| LACTATED RINGER'S INJECTION USP (600 MG) | 01931636 | Marketed | B. Braun Medical AG | Sep 1998 |
| LACTATED RINGER'S INJECTION, USP (600 MG) | 00061085 | Marketed | Baxter Corporation | Dec 1957 |
| LACTATED RINGER'S IRRIGATION (600 MG) | 00758566 | Marketed | Icu Medical Canada Inc | Dec 2019 |
| LACTATED RINGER'S IRRIGATION SOL (600 MG) | 00799971 | Marketed | Baxter Corporation | Dec 1989 |
| LMD 10% IN 0.9% SODIUM CHLORIDE (0.9 %) | 00224227 | Marketed | Pfizer Canada Ulc | Sep 2017 |
| MOVIPREP (2.691 G) | 02359499 | Marketed | Aralez Pharmaceuticals Canada Inc. | Aug 2020 |
| NATURALYTE H-200 (263 G) | 02330172 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-201 (263 G) | 02330024 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-208 (263 G) | 02329980 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-225 (263 G) | 02327465 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-226 (263 G) | 02327406 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-229 (263 G) | 02326949 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-232 (263 G) | 02330253 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-260 (289.3 G) | 02327384 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-320 (289.3 G) | 02330229 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-330 (263 G) | 02327503 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-332 (263 G) | 02327333 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-401 (263 G) | 02327309 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-402 (263 G) | 02327422 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-408 (263 G) | 02327538 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-410 (263 G) | 02327511 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-616 (263.0 G) | 02327066 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-623 (263 G) | 02330016 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-624 (263 G) | 02330032 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NEOGEN VIROXIDE SUPER (1.5 %) | 02525100 | Marketed | Preserve Inc | Aug 2022 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304) (116.6 G) | 02363631 | Marketed | Nxstage Medical, Inc. | Nov 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301) (116.6 G) | 02363615 | Marketed | Nxstage Medical, Inc. | Dec 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302) (122.64 G) | 02363666 | Marketed | Nxstage Medical, Inc. | Jul 2013 |
| NXSTAGE PUREFLOW SOLUTION (5.844 G) | 02443279 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (5.552 G) | 02443287 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (5.552 G) | 02443295 | Marketed | Nxstage Medical, Inc. | Aug 2026 |
| OPTICLEAR LIQ 0.44% (0.44 %) | 00869333 | Marketed | Tomlyn Products Division Of Vetoquinol Usa Inc. | Dec 1990 |
| PEGLYTE POWDER (5.85 G) | 00777838 | Marketed | Pendopharm Division Of Pharmascience Inc | May 2013 |
| PH 12 STERILE DILUENT FOR FLOLAN (73.3 MG) | 02443651 | Marketed | Glaxosmithkline Inc | Aug 2016 |
| PHENOL SALINE INJ (0.9 %) | 00298409 | Marketed | Alk-Abello Inc | Jan 2005 |
| PHYSIONEAL 40 GLUCOSE 1.36% (8.43 G) | 02247721 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX (19.95 G) | 02368730 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% (8.43 G) | 02247722 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% CLEAR-FLEX (19.95 G) | 02368757 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% (8.43 G) | 02247723 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% CLEAR-FLEX (19.95 G) | 02368749 | Marketed | Vantive Ulc | May 2024 |
| PLASMA-LYTE A INJECTION (526 MG) | 02339358 | Marketed | Baxter Corporation | Dec 2010 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR (900 MG) | 00786306 | Marketed | Baxter Corporation | Dec 1990 |
| POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION (600 MG) | 02243421 | Marketed | Baxter Corporation | May 2001 |
| POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP (450 MG) | 02269414 | Marketed | Baxter Corporation | Mar 2008 |
| PRISM0CAL (6.449 G) | 02274876 | Marketed | Vantive Ulc | Apr 2024 |
| PRISM0CAL B22K0/0 (7.14 G) | 02441691 | Marketed | Vantive Ulc | Apr 2024 |
| PRISMASOL 0 (6.45 G) | 02243095 | Marketed | Vantive Ulc | Apr 2024 |
| PRISMASOL 4 (6.45 G) | 02277476 | Marketed | Vantive Ulc | Apr 2024 |
| QUENCH LYTE (320 MG) | 02229713 | Marketed | Dominion Veterinary Laboratories Ltd. | Apr 1999 |
| REGIOCIT (5.03 G) | 02496755 | Marketed | Vantive Ulc | May 2024 |
| SALINE 0.9% (0.9 G) | 02519372 | Marketed | Dmvet Inc | Feb 2022 |
| SCLERODEX (100 MG) | 02020939 | Marketed | Omega Laboratories Limited | Dec 1977 |
| SODIUM CHLORIDE 0.45% INJ (450 MG) | 00060186 | Marketed | Baxter Corporation | Dec 1990 |
| SODIUM CHLORIDE 3% INJ (3 G) | 00060232 | Marketed | Baxter Corporation | Dec 1990 |
| SODIUM CHLORIDE BACTERIOSTATIC INJ (9 MG) | 00402249 | Marketed | Omega Laboratories Limited | Dec 1977 |
| SODIUM CHLORIDE INJECTION USP (9 MG) | 00037796 | Marketed | Pfizer Canada Ulc | Aug 2017 |
| SODIUM CHLORIDE INJECTION USP (9 MG) | 00037842 | Marketed | Icu Medical Canada Inc | Feb 2020 |
| SODIUM CHLORIDE INJECTION USP, 0.9% W/V (9 MG) | 02560100 | Marketed | Sterinova Inc. | May 2026 |
| SODIUM CHLORIDE INJECTION, USP (234 MG) | 02139510 | Marketed | Fresenius Kabi Canada Ltd | Nov 2015 |
| SODIUM CHLORIDE IRRIGATION USP (9 MG) | 00037834 | Marketed | Icu Medical Canada Inc | Feb 2020 |
| SODIUM CHLORIDE IRRIGATION USP (9 MG) | 00037826 | Marketed | Icu Medical Canada Inc | Oct 2019 |
| SSP+ (4.05 G) | 02492067 | Marketed | Maco Pharma | Nov 2021 |
| SSP+ (4.05 G) | 02492075 | Marketed | Maco Pharma | Dec 2022 |
| SULFAVITE (2.8 G) | 00721069 | Marketed | Dominion Veterinary Laboratories Ltd. | Jan 2018 |
| TIS-U-SOL SOLUTION (800 MG) | 00800007 | Marketed | Baxter Corporation | Dec 1990 |
| TPN ELECTROLYTES (16.05 MG) | 00590215 | Marketed | Pfizer Canada Ulc | Aug 2017 |
| V-LYTES (WATER SOLUBLE ELECTROLYTE POWDER) (4.675 G) | 02047519 | Marketed | Vetoquinol N A Inc | Dec 1993 |
| V-LYTES HE (WATER SOLUBLE NUTRIENT, ELECTROLYTE POWDER FOR ORAL USE IN CALVES) (4.675 G) | 01957341 | Marketed | Vetoquinol N A Inc | Jul 2007 |
| VET-LACTR (6 G) | 02519429 | Marketed | Dmvet Inc | Jan 2022 |
| VETALYTE (4.8 MG) | 02426536 | Marketed | Dmvet Inc | Oct 2014 |
| VITA PRO SOLUBLE (277.71 G) | 02324415 | Marketed | Matrix Environmental Solutions Ltd | Mar 2012 |
| 0.9% SODIUM CHLORIDE INJECTION, USP (0.9 %) | 02533537 | Approved | Laboratorios Grifols S.A. | Dec 2022 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP (0.9 %) | 01963937 | Dormant | B. Braun Medical AG | Jul 2019 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP (0.9 %) | 02530600 | Approved | B. Braun Medical AG | Sep 2022 |
| 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (300 MG) | 01927981 | Dormant | B. Braun Medical AG | Jul 2020 |
| 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP (200 MG) | 01927558 | Dormant | B. Braun Medical AG | Jul 2017 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (4.5 MG) | 00038903 | Dormant | Icu Medical Canada Inc | Jul 2026 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE (9 MG) | 00038946 | Dormant | Icu Medical Canada Inc | Dec 2025 |
| ACID CONCENTRATE A1220 (263 G) | 02381257 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1229 (263 G) | 02533901 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1251 (275 G) | 02533790 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1253 (275 G) | 02248823 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1264 (263 G) | 02262509 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1268 (263 G) | 02262541 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1269 (263 G) | 02262568 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1271 (289.3 G) | 02272520 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1272 (263 G) | 02272539 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1273 (263 G) | 02272547 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1274 (263 G) | 02272555 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1276 (263 G) | 02272571 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1278 (289.3 G) | 02272601 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1280 (263 G) | 02272636 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1295 (263 G) | 02435888 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ADDITIVE SOLUTION FORMULA 3 AS-3 (0.410 G) | 02324393 | Dormant | Terumo Bct, Inc. | Sep 2025 |
| AMINO BOLUSES IMPROVED (2 G) | 00319333 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| AVL SALINE INJECTION (0.9 %) | 02396645 | Approved | Alberta Veterinary Laboratories Ltd | Nov 2012 |
| BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP (9 MG) | 02516284 | Approved | Marcan Pharmaceuticals Inc. | May 2021 |
| BALANCE 1.5% GLUCOSE, 1.75 MMOL/L CALCIUM (5.64 G) | 02261022 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 2.3% GLUCOSE, 1.75 MMOL/L CALCIUM (5.64 G) | 02261049 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 4.25% GLUCOSE, 1.75 MMOL/L CALCIUM (5.64 G) | 02261030 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCED SALT SOLUTION (6.4 MG) | 02023709 | Dormant | Pharma Stulln Inc. | Sep 2019 |
| CALF-QUENCH (3.507 G) | 02495767 | Approved | Dominion Veterinary Laboratories Ltd. | Jan 2020 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (567 MG) | 02453010 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (567 MG) | 02453029 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (538 MG) | 02453037 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (538 MG) | 02453045 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (538 MG) | 02472880 | Approved | Chief Medical Supplies Ltd | Feb 2018 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (567 MG) | 02473747 | Approved | Chief Medical Supplies Ltd | Mar 2018 |
| CITRASATE C0125 (263 G) | 02366533 | Dormant | Chief Medical Supplies Ltd | Jun 2021 |
| CITRASATE C10125 (263 G) | 02325640 | Approved | Chief Medical Supplies Ltd | Apr 2009 |
| CITRASATE C1125 (263 G) | 02366541 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C1150 (263 G) | 02366592 | Dormant | Chief Medical Supplies Ltd | Aug 2018 |
| CITRASATE C2125 (263 G) | 02366568 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C2150 (263 G) | 02366606 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3125 (263 G) | 02366576 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3150 (263 G) | 02366614 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C4125 (263 G) | 02366584 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| DEXTROSE PLUS ELECTROLYTES (4.59 G) | 00308366 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| DIALYSIS SOLUTION 35 K0 (7.66 G) | 02294753 | Dormant | Chief Medical Supplies Ltd | Sep 2020 |
| DIALYSIS SOLUTION 35 K2 (7.66 G) | 02294761 | Approved | Chief Medical Supplies Ltd | Sep 2020 |
| DIALYSIS SOLUTION 35 K4 (7.66 G) | 02294788 | Dormant | Chief Medical Supplies Ltd | Sep 2020 |
| DILUENT FOR ALLERGENIC EXTRACT STERILE NORMAL SALINE WITH PHENOL (0.4%) (0.9 %) | 02407116 | Approved | Jubilant Hollisterstier Llc | May 2013 |
| ELECTRA CAPS (2.5872 G) | 00345342 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| ELECTROLYTE INFUSION STERILE INJECTION (5.5 G) | 00715654 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| ELECTROLYTE TAB (2.5872 G) | 00370452 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| ENTEROLYTE (209 MG) | 02031353 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| EQUINE PERFORMANCE PWS (41.52 G) | 02010984 | Dormant | Davis And Lawrence Co. | Jul 2018 |
| H.E.L.P. NACI 0.9% (9 G) | 02373815 | Dormant | B. Braun Avitum Ag | Jul 2025 |
| H.E.L.P.BICEL (4.21 G) | 02373793 | Dormant | B. Braun Avitum Ag | Jul 2025 |
| HEMASATE ULTRA HS0125 (263 G) | 02422557 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1125 (263 G) | 02422573 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1150 (263 G) | 02422565 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2125 (263 G) | 02422581 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2150 (263 G) | 02422409 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3125 (263 G) | 02422603 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3150 (263 G) | 02422611 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS4125 (263 G) | 02422417 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMOSATE ULTRA HS0125 (263 G) | 02413876 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS1150 (263 G) | 02413930 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2150 (263 G) | 02413957 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| HEMOSATE ULTRA HS3150 (263 G) | 02413965 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION (900 MG) | 01935933 | Dormant | B. Braun Medical AG | Jul 2017 |
| JAMP-ELECTROPEG (5.86 G) | 02406780 | Approved | JAMP Pharma Corporation | May 2013 |
| JAMP-ELECTROPEG WITH FLAVOUR PACKET (5.86 G) | 02406799 | Approved | JAMP Pharma Corporation | May 2013 |
| JAMPLYTE (1.46 G) | 02368234 | Approved | JAMP Pharma Corporation | May 2011 |
| LACT R (6 G) | 00715530 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| LACTATE 1-2-3 INJECTION (3 MG) | 00039306 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| LACTATED RINGER'S INJECTION USP (6 G) | 02375443 | Dormant | Rafter 8 Products Inc | Jul 2023 |
| LACTATED RINGERS INJECTION USP (6.00 G) | 02399911 | Approved | Alberta Veterinary Laboratories Ltd | Jan 2013 |
| NATURALYTE H-228 (263 G) | 02327104 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-230 (263 G) | 02330180 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-321 (289.3 G) | 02326930 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-407 (262.99 G) | 02327392 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-615 (263.0 G) | 02327473 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-625 (263.0 G) | 02327031 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-630 (263.0 G) | 02330040 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-631 (263 G) | 02327090 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-706 (263 G) | 02327058 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NORMOSOL-M & 5% DEXTROSE (0.234 G) | 00039489 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| NORMOSOL-R (0.526 G) | 00039500 | Dormant | Icu Medical Canada Inc | Jul 2025 |
| NORMOSOL-R & 5% DEXTROSE (0.526 G) | 00039640 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303) (116.6 G) | 02363623 | Dormant | Nxstage Medical, Inc. | May 2020 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) (116.6 G) | 02363658 | Dormant | Nxstage Medical, Inc. | May 2020 |
| ODAN BALANCED SALT SOLUTION (6.4 MG) | 00622893 | Dormant | Odan Laboratoriesltd | Jun 2017 |
| PHYSIOLOGICAL SALINE (4.5 G) | 00715573 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| PMS-PEGLYTE (5.85 G) | 02471590 | Approved | Pharmascience Inc. | Jan 2018 |
| POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE (0.9 G) | 02299100 | Dormant | Icu Medical Canada Inc | May 2023 |
| POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE (0.3 G) | 00472085 | Dormant | Icu Medical Canada Inc | Oct 2023 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.225% SODIUM CHLORIDE (0.225 G) | 00466689 | Dormant | Icu Medical Canada Inc | Nov 2018 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (0.45 G) | 00466670 | Dormant | Icu Medical Canada Inc | Mar 2023 |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (0.45 G) | 00603244 | Dormant | Icu Medical Canada Inc | Oct 2023 |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE (0.9 G) | 02299135 | Dormant | Icu Medical Canada Inc | Sep 2022 |
| PRISMASOL 2 (6.45 G) | 02277441 | Dormant | Vantive Ulc | Apr 2024 |
| REVIBE (4.675 G) | 00859613 | Dormant | Phibro Animal Health Corporation | May 2026 |
| REVIBE H.E. (4.675 G) | 00890006 | Dormant | Phibro Animal Health Corporation | May 2026 |
| RINGER'S INJECTION USP (860 MG) | 01936034 | Dormant | B. Braun Medical AG | Feb 2024 |